11
Participants
Start Date
June 30, 2012
Primary Completion Date
April 30, 2013
Study Completion Date
February 28, 2014
Maraviroc (5 days)
Subjects will receive maraviroc 150 mg tablets (1 tablet) every 12 hours from days 1 to 5 inclusively.
Maraviroc and boceprevir (14 days)
From days 6 to 19, inclusively, boceprevir 800 mg (4 capsules of 200 mg) every 8 hours with food will be given with maraviroc 150 mg (1 tablet of 150 mg) every 12 hours.
Centre Hospitalier de l'Université de Montréal, Montreal
Université de Montréal
OTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Toronto General Hospital
OTHER
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER